S&P 500   3,940.67 (+0.61%)
DOW   32,149.63 (+0.90%)
QQQ   305.19 (-0.06%)
AAPL   157.44 (+1.57%)
MSFT   270.94 (-3.04%)
META   197.27 (+0.85%)
GOOGL   101.27 (-0.34%)
AMZN   97.12 (-1.85%)
TSLA   183.42 (+1.83%)
NVDA   259.05 (+0.70%)
NIO   8.72 (+5.57%)
BABA   80.86 (-0.99%)
AMD   96.51 (-1.36%)
T   18.45 (+1.77%)
F   11.20 (-0.88%)
MU   57.17 (+0.90%)
CGC   1.87 (-6.50%)
GE   89.95 (-0.38%)
DIS   93.91 (+0.76%)
AMC   4.28 (+2.39%)
PFE   40.64 (+1.35%)
PYPL   72.66 (-0.45%)
NFLX   304.97 (+0.48%)
S&P 500   3,940.67 (+0.61%)
DOW   32,149.63 (+0.90%)
QQQ   305.19 (-0.06%)
AAPL   157.44 (+1.57%)
MSFT   270.94 (-3.04%)
META   197.27 (+0.85%)
GOOGL   101.27 (-0.34%)
AMZN   97.12 (-1.85%)
TSLA   183.42 (+1.83%)
NVDA   259.05 (+0.70%)
NIO   8.72 (+5.57%)
BABA   80.86 (-0.99%)
AMD   96.51 (-1.36%)
T   18.45 (+1.77%)
F   11.20 (-0.88%)
MU   57.17 (+0.90%)
CGC   1.87 (-6.50%)
GE   89.95 (-0.38%)
DIS   93.91 (+0.76%)
AMC   4.28 (+2.39%)
PFE   40.64 (+1.35%)
PYPL   72.66 (-0.45%)
NFLX   304.97 (+0.48%)
S&P 500   3,940.67 (+0.61%)
DOW   32,149.63 (+0.90%)
QQQ   305.19 (-0.06%)
AAPL   157.44 (+1.57%)
MSFT   270.94 (-3.04%)
META   197.27 (+0.85%)
GOOGL   101.27 (-0.34%)
AMZN   97.12 (-1.85%)
TSLA   183.42 (+1.83%)
NVDA   259.05 (+0.70%)
NIO   8.72 (+5.57%)
BABA   80.86 (-0.99%)
AMD   96.51 (-1.36%)
T   18.45 (+1.77%)
F   11.20 (-0.88%)
MU   57.17 (+0.90%)
CGC   1.87 (-6.50%)
GE   89.95 (-0.38%)
DIS   93.91 (+0.76%)
AMC   4.28 (+2.39%)
PFE   40.64 (+1.35%)
PYPL   72.66 (-0.45%)
NFLX   304.97 (+0.48%)
S&P 500   3,940.67 (+0.61%)
DOW   32,149.63 (+0.90%)
QQQ   305.19 (-0.06%)
AAPL   157.44 (+1.57%)
MSFT   270.94 (-3.04%)
META   197.27 (+0.85%)
GOOGL   101.27 (-0.34%)
AMZN   97.12 (-1.85%)
TSLA   183.42 (+1.83%)
NVDA   259.05 (+0.70%)
NIO   8.72 (+5.57%)
BABA   80.86 (-0.99%)
AMD   96.51 (-1.36%)
T   18.45 (+1.77%)
F   11.20 (-0.88%)
MU   57.17 (+0.90%)
CGC   1.87 (-6.50%)
GE   89.95 (-0.38%)
DIS   93.91 (+0.76%)
AMC   4.28 (+2.39%)
PFE   40.64 (+1.35%)
PYPL   72.66 (-0.45%)
NFLX   304.97 (+0.48%)
NYSE:BIO.B

Bio-Rad Laboratories - BIO.B News Today

$464.10
+72.94 (+18.65%)
(As of 03/20/2023 02:47 PM ET)
Add
Compare
Today's Range
$464.10
▼
$464.10
50-Day Range
$404.66
▼
$404.66
52-Week Range
$355.36
▼
$750.16
Volume
235 shs
Average Volume
429 shs
Market Capitalization
$13.74 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter.


BIO.B Media Mentions By Week

BIO.B Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIO.B
News Sentiment
▼
0.00

0.35
▲
Average
Medical
News Sentiment

BIO.B News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIO.B Articles
This Week
▼
0

0
▲
BIO.B Articles
Average Week

SourceHeadline
markets.businessinsider.com logoAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Zimmer Biomet Holdings (ZBH)
markets.businessinsider.com - March 9 at 10:18 AM
msn.com logoBio-Rad (BIO) Global Expansion Strong, FX Woe Dents Growth
msn.com - March 9 at 10:18 AM
thestreet.com logoBio-Rad Laboratories (BIO) Upgraded From Hold to Buy
thestreet.com - January 15 at 8:24 PM
markets.businessinsider.com logoGT Molecular Releases Respiratory Panels and Poliovirus Typing Assays for Leading PCR Platforms
markets.businessinsider.com - December 20 at 8:15 PM
msn.com logoBio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins Down
msn.com - October 28 at 9:19 PM
msn.com logoBio-Rad Laboratories (BIO) Surpasses Q3 Earnings Estimates
msn.com - October 27 at 7:53 PM
msn.com logoBio-Rad Laboratories, Qiagen Mull Merger Of Equals
msn.com - October 11 at 8:34 AM
bizjournals.com logoEast Bay life sciences company reportedly in talks with Qiagen in $10 billion deal
bizjournals.com - October 10 at 5:31 PM
benzinga.com logoThe Global Flow Cytometry Market size is expected to reach $7.7 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period
benzinga.com - September 29 at 4:33 PM
finance.yahoo.com logoIs Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?
finance.yahoo.com - June 20 at 7:02 AM
thestreet.com logoBio-Rad Laboratories Inc. Class A
thestreet.com - June 13 at 3:14 AM
finance.yahoo.com logoThe 4.8% return this week takes Bio-Rad Laboratories' (NYSE:BIO) shareholders five-year gains to 140%
finance.yahoo.com - May 28 at 10:15 AM
finance.yahoo.com logoWall Street Analysts Believe Bio-Rad (BIO) Could Rally 53%: Here's is How to Trade
finance.yahoo.com - May 25 at 12:04 PM
apnews.com logoWorldwide Mononucleosis Diagnostic Industry to 2027 - Rising Health Awareness and Knowledge Among Patients is Driving Growth - ResearchAndMarkets.com
apnews.com - April 25 at 3:21 PM
sg.finance.yahoo.com logoPolymerase Chain Reaction Market to Advance at CAGR of 6.4% During 2021–2028, Says TMR
sg.finance.yahoo.com - April 17 at 1:05 PM
nasdaq.com logoEarnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline
nasdaq.com - February 3 at 5:49 PM
uk.finance.yahoo.com logoOutlook on the Cell Isolation Global Market to 2026 - by Technique, Cell Type, Product, Application, End-use and Region - ResearchAndMarkets.com
uk.finance.yahoo.com - December 15 at 3:23 PM
finance.yahoo.com logoHedge Funds Are Selling Bio-Rad Laboratories, Inc. (BIO)
finance.yahoo.com - December 8 at 12:56 PM
finance.yahoo.com logoBio Rad (BIO) Grows Internationally on New Product Launches
finance.yahoo.com - November 25 at 12:38 PM
benzinga.com logoOutlook on the Cell Sorting Global Market to 2026...
benzinga.com - November 10 at 11:14 PM
barrons.com logoBio-Rad Laboratories Inc. Cl B
barrons.com - November 5 at 7:35 PM
msn.com logoBio-Rad Laboratories (BIO) Is Up 0.05% in One Week: What You Should Know
msn.com - September 14 at 3:18 PM
forbes.com logoBio-Rad Laboratories (BIO)
forbes.com - August 25 at 8:22 PM
barrons.com logoQuidel Corp.
barrons.com - December 5 at 1:51 AM
nasdaq.com logoBio-Rad Laboratories, Inc. Class B Common Stock (BIO.B)
nasdaq.com - October 19 at 8:54 PM
markets.businessinsider.com logoBio-Rad Laboratories Inc. Buy
markets.businessinsider.com - August 18 at 9:16 AM
markets.ft.com logoBio Rad Laboratories Inc
markets.ft.com - November 21 at 9:32 PM
www.fool.com logoBio-Rad Laboratories Inc (BIO) (BIO-B) Q2 2019 Earnings Call Transcript
www.fool.com - August 1 at 9:09 PM
www.nasdaq.com logoBio-Rad Laboratories, Inc. Class B Common Stock Real Time Stock Quotes
www.nasdaq.com - June 17 at 3:57 PM
Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter.

This page (NYSE:BIO.B) was last updated on 3/20/2023 by MarketBeat.com Staff